Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

SEIS: Insight's Seismic Experiment for Internal Structure of Mars.

Lognonné P, Banerdt WB, Giardini D, Pike WT, Christensen U, Laudet P, de Raucourt S, Zweifel P, Calcutt S, Bierwirth M, Hurst KJ, Ijpelaan F, Umland JW, Llorca-Cejudo R, Larson SA, Garcia RF, Kedar S, Knapmeyer-Endrun B, Mimoun D, Mocquet A, Panning MP, Weber RC, Sylvestre-Baron A, Pont G, Verdier N, Kerjean L, Facto LJ, Gharakanian V, Feldman JE, Hoffman TL, Klein DB, Klein K, Onufer NP, Paredes-Garcia J, Petkov MP, Willis JR, Smrekar SE, Drilleau M, Gabsi T, Nebut T, Robert O, Tillier S, Moreau C, Parise M, Aveni G, Ben Charef S, Bennour Y, Camus T, Dandonneau PA, Desfoux C, Lecomte B, Pot O, Revuz P, Mance D, tenPierick J, Bowles NE, Charalambous C, Delahunty AK, Hurley J, Irshad R, Liu H, Mukherjee AG, Standley IM, Stott AE, Temple J, Warren T, Eberhardt M, Kramer A, Kühne W, Miettinen EP, Monecke M, Aicardi C, André M, Baroukh J, Borrien A, Bouisset A, Boutte P, Brethomé K, Brysbaert C, Carlier T, Deleuze M, Desmarres JM, Dilhan D, Doucet C, Faye D, Faye-Refalo N, Gonzalez R, Imbert C, Larigauderie C, Locatelli E, Luno L, Meyer JR, Mialhe F, Mouret JM, Nonon M, Pahn Y, Paillet A, Pasquier P, Perez G, Perez R, Perrin L, Pouilloux B, Rosak A, Savin de Larclause I, Sicre J, Sodki M, Toulemont N, Vella B, Yana C, Alibay F, Avalos OM, Balzer MA, Bhandari P, Blanco E, Bone BD, Bousman JC, Bruneau P, Calef FJ, Calvet RJ, D'Agostino SA, de Los Santos G, Deen RG, Denise RW, Ervin J, Ferraro NW, Gengl HE, Grinblat F, Hernandez D, Hetzel M, Johnson ME, Khachikyan L, Lin JY, Madzunkov SM, Marshall SL, Mikellides IG, Miller EA, Raff W, Singer JE, Sunday CM, Villalvazo JF, Wallace MC, Banfield D, Rodriguez-Manfredi JA, Russell CT, Trebi-Ollennu A, Maki JN, Beucler E, Böse M, Bonjour C, Berenguer JL, Ceylan S, Clinton J, Conejero V, Daubar I, Dehant V, Delage P, Euchner F, Estève I, Fayon L, Ferraioli L, Johnson CL, Gagnepain-Beyneix J, Golombek M, Khan A, Kawamura T, Kenda B, Labrot P, Murdoch N, Pardo C, Perrin C, Pou L, Sauron A, Savoie D, Stähler S, Stutzmann E, Teanby NA, Tromp J, van Driel M, Wieczorek M, Widmer-Schnidrig R, Wookey J.

Space Sci Rev. 2019;215(1):12. doi: 10.1007/s11214-018-0574-6. Epub 2019 Jan 28. Review.

2.

Socioeconomic determinants of health inequalities among the older population in India: a decomposition analysis.

Goli S, Singh L, Jain K, Pou LM.

J Cross Cult Gerontol. 2014 Dec;29(4):353-69. doi: 10.1007/s10823-014-9251-8.

PMID:
25349021
3.

High intra-individual variability of cyclosporine pharmacokinetics in lung transplant recipients without cystic fibrosis.

Méndez A, Monforte V, Berastegui C, López-Meseguer M, Bravo C, Pou L, Roman A.

Clin Transplant. 2014 Jun;28(6):743-8. doi: 10.1111/ctr.12371. Epub 2014 May 14.

PMID:
24708188
4.

Pharmacokinetic study of conversion from tacrolimus twice-daily to tacrolimus once-daily in stable lung transplantation.

Méndez A, Berastegui C, López-Meseguer M, Monforte V, Bravo C, Blanco A, Camós S, Pou L, Roman A.

Transplantation. 2014 Feb 15;97(3):358-62. doi: 10.1097/01.TP.0000435699.69266.66.

PMID:
24492423
5.

Determination of ganciclovir in human plasma by ultra performance liquid chromatography-UV detection.

Padullés A, Colom H, Armendariz Y, Cerezo G, Caldes A, Pou L, Torras J, Grinyó JM, Lloberas N.

Clin Biochem. 2012 Mar;45(4-5):309-14. doi: 10.1016/j.clinbiochem.2011.12.014. Epub 2012 Jan 4.

PMID:
22245106
6.

Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.

Soler-Palacín P, Frick MA, Martín-Nalda A, Lanaspa M, Pou L, Roselló E, de Heredia CD, Figueras C.

J Antimicrob Chemother. 2012 Mar;67(3):700-6. doi: 10.1093/jac/dkr517. Epub 2011 Dec 21.

PMID:
22190607
7.

State of the art in therapeutic drug monitoring.

Llorente Fernández E, Parés L, Ajuria I, Bandres F, Castanyer B, Campos F, Farré C, Pou L, Queraltó JM, To-Figueras J.

Clin Chem Lab Med. 2010 Apr;48(4):437-46. doi: 10.1515/CCLM.2010.111. Review.

PMID:
20187852
8.

Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics.

Caldés A, Gil-Vernet S, Armendariz Y, Colom H, Pou L, Niubó J, Lladó L, Torras J, Manito N, Rufí G, Grinyó JM.

Transpl Infect Dis. 2010 Jun;12(3):204-12. doi: 10.1111/j.1399-3062.2009.00481.x. Epub 2009 Dec 9.

PMID:
20002612
9.

Population pharmacokinetics of ganciclovir after intravenous ganciclovir and oral valganciclovir administration in solid organ transplant patients infected with cytomegalovirus.

Caldés A, Colom H, Armendariz Y, Garrido MJ, Troconiz IF, Gil-Vernet S, Lloberas N, Pou L, Peraire C, Grinyó JM.

Antimicrob Agents Chemother. 2009 Nov;53(11):4816-24. doi: 10.1128/AAC.00085-09. Epub 2009 Sep 8.

10.

Indications and management of everolimus after liver transplantation.

Bilbao I, Sapisochin G, Dopazo C, Lazaro JL, Pou L, Castells L, Caralt M, Blanco L, Gantxegi A, Margarit C, Charco R.

Transplant Proc. 2009 Jul-Aug;41(6):2172-6. doi: 10.1016/j.transproceed.2009.06.087.

PMID:
19715864
11.

Impact of valganciclovir on Epstein-Barr Virus polymerase chain reaction in pediatric liver transplantation: preliminary report.

Venturi C, Bueno J, Gavalda J, Tórtola T, Pou L, Medina A, Codina G, Charco R, Pahissa A.

Transplant Proc. 2009 Apr;41(3):1038-40. doi: 10.1016/j.transproceed.2009.02.053.

PMID:
19376420
12.

Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety.

Monforte V, Ussetti P, López R, Gavaldà J, Bravo C, de Pablo A, Pou L, Pahissa A, Morell F, Román A.

J Heart Lung Transplant. 2009 Feb;28(2):170-5. doi: 10.1016/j.healun.2008.11.004.

PMID:
19201343
13.

Early monitoring of ribavirin serum concentration is not useful to optimize hepatitis C virus treatment in HIV-coinfected patients.

Crespo M, Pou L, Esteban JI, Falcó V, Ribera E, Lopez R, Sauleda S, Curran A, Villar del Saz S, Feijoo M, Ocaña I, Pahissa A.

Antivir Ther. 2007;12(8):1217-23.

PMID:
18240861
14.

Efficacy and safety of 'rescue therapy' with mycophenolate mofetil in resistant primary glomerulonephritis--a multicenter study.

Segarra A, Amoedo ML, Martinez Garcia JM, Pons S, Praga M, Garcia EI, Alonso JC, Gascó JM, Pou L, Piera L.

Nephrol Dial Transplant. 2007 May;22(5):1351-60. Epub 2007 Feb 20.

PMID:
17311833
15.

Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.

Ribera E, Azuaje C, Lopez RM, Domingo P, Curran A, Feijoo M, Pou L, Sánchez P, Sambeat MA, Colomer J, Lopez-Colomes JL, Crespo M, Falcó V, Ocaña I, Pahissa A.

J Antimicrob Chemother. 2007 Apr;59(4):690-7. Epub 2007 Feb 16.

PMID:
17307771
16.

Immunosuppression based on mycophenolate mofetil in stable liver transplanted patients.

Bilbao I, Castells L, Rojas L, Cancino J, Dopazo C, Castro E, Pou L, Andino R, Margarit C.

Int Immunopharmacol. 2006 Dec 20;6(13-14):1977-83. Epub 2006 Oct 24.

PMID:
17161351
17.

Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimen.

Ribera E, Azuaje C, Lopez RM, Diaz M, Feijoo M, Pou L, Crespo M, Curran A, Ocaña I, Pahissa A.

AIDS. 2006 May 12;20(8):1131-9.

PMID:
16691064
18.

Hematocrit influences immunoassay performance for the measurement of tacrolimus in whole blood.

Armendáriz Y, García S, Lopez RM, Pou L.

Ther Drug Monit. 2005 Dec;27(6):766-9.

PMID:
16306852
19.

A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C.

Margarit C, Bilbao I, Castells L, Lopez I, Pou L, Allende E, Escartin A.

Transpl Int. 2005 Dec;18(12):1336-45.

20.

Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study).

Ribera E, Azuaje C, Lopez RM, Domingo P, Soriano A, Pou L, Sánchez P, Mallolas J, Sambea MA, Falco V, Ocaña I, Lopez-Colomes JL, Gatell JM, Pahissa A.

J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):317-23.

PMID:
16249706
21.

Evaluation of a limited sampling strategy to estimate area under the curve of tacrolimus in adult renal transplant patients.

Armendáriz Y, Pou L, Cantarell C, Lopez R, Perelló M, Capdevila L.

Ther Drug Monit. 2005 Aug;27(4):431-4.

PMID:
16044098
22.

Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults.

Ribera E, Lopez RM, Diaz M, Pou L, Ruiz L, Falcó V, Crespo M, Azuaje C, Ruiz I, Ocaña I, Clotet B, Pahissa A.

Antimicrob Agents Chemother. 2004 Nov;48(11):4256-62.

23.

Pharmacokinetics of oral valganciclovir and intravenous ganciclovir administered to prevent cytomegalovirus disease in an adult patient receiving small-intestine transplantation.

Fortún Abete J, Martín-Dávila P, Moreno S, Quijano Y, de Vicente E, Pou L.

Antimicrob Agents Chemother. 2004 Jul;48(7):2782-3. No abstract available.

24.

Blood cyclosporine C0 and C2 concentrations and cytomegalovirus infections following lung transplantation.

Monforte V, Bullich S, Pou L, Bravo C, López R, Gavaldà J, Roman A.

Transplant Proc. 2003 Aug;35(5):1992-3.

PMID:
12962872
25.

Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients.

Monforte V, Roman A, Gavaldá J, López R, Pou L, Simó M, Aguadé S, Soriano B, Bravo C, Morell F.

Transplantation. 2003 May 15;75(9):1571-4.

PMID:
12792517
26.
27.

Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis.

Ribera E, Pou L, Lopez RM, Crespo M, Falco V, Ocaña I, Ruiz I, Pahissa A.

J Acquir Immune Defic Syndr. 2001 Dec 15;28(5):450-3.

PMID:
11744833
28.

Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients.

Ribera E, Pou L, Fernandez-Sola A, Campos F, Lopez RM, Ocaña I, Ruiz I, Pahissa A.

Antimicrob Agents Chemother. 2001 Nov;45(11):3238-41.

29.

Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.

Bilbao I, Pou L, Allende E, Lázaro JL, Charco R, Hidalgo E, Margarit C.

Transplant Proc. 2001 May;33(3):2124-6. No abstract available.

PMID:
11377472
30.

Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.

López P, Gavaldà J, Martin MT, Almirante B, Gomis X, Azuaje C, Borrell N, Pou L, Falcó V, Pigrau C, Pahissa A.

Antimicrob Agents Chemother. 2001 May;45(5):1387-93.

31.

Simple and rapid determination of nevirapine in human serum by reversed-phase high-performance liquid chromatography.

Lopez RM, Pou L, Gomez MR, Ruiz I, Monterde J.

J Chromatogr B Biomed Sci Appl. 2001 Feb 25;751(2):371-6.

PMID:
11236094
32.

Mycophenolic acid plasma concentrations: influence of comedication.

Pou L, Brunet M, Cantarell C, Vidal E, Oppenheimer F, Monforte V, Vilardell J, Roman A, Martorell J, Capdevila L.

Ther Drug Monit. 2001 Feb;23(1):35-8.

PMID:
11206040
33.

Mycophenolate mofetil pharmacokinetics in transplant patients receiving cyclosporine or tacrolimus in combination therapy.

Vidal E, Cantarell C, Capdevila L, Monforte V, Roman A, Pou L.

Pharmacol Toxicol. 2000 Oct;87(4):182-4.

PMID:
11097273
34.

Determination of lamotrigine in human serum by liquid chromatography.

Vidal E, Pascual C, Pou L.

J Chromatogr B Biomed Sci Appl. 1999 Dec 24;736(1-2):295-8.

PMID:
10677010
35.

Multicenter comparison of first- and second-generation IMx tacrolimus microparticle enzyme immunoassays in liver and kidney transplantation.

Brunet M, Pou L, Manzanares C, Palacios G, Corbella J.

Ther Drug Monit. 1998 Dec;20(6):676-9.

PMID:
9853987
36.

Therapeutic drug monitoring of tacrolimus in liver transplantation, phase III FK506 multicenter Spanish Study Group: a two-year follow-up.

Pou L, Brunet M, Bilbao I, Andreu H, Andres I, Lopez R, Margarit C, Rimola A, Corbella J.

Ther Drug Monit. 1998 Dec;20(6):602-6.

PMID:
9853973
37.

Amphotericin B determination in respiratory secretions by reversed-phase liquid chromatography.

Lopez R, Pou L, Andres I, Monforte V, Roman A, Pascual C.

J Chromatogr A. 1998 Jul 3;812(1-2):135-9.

PMID:
9691314
38.

Influence of posttransplant time on dose and concentration of tacrolimus in liver transplant patients.

Pou L, Brunet M, Andres I, Rodamilans M, Lopez R, Corbella J.

Transpl Int. 1998;11 Suppl 1:S270-1.

PMID:
9664994
39.

Experience with neoral cyclosporine through the oral route in liver transplantation.

Bilbao I, Lazaro JL, Pou L, Charco R, Hildalgo E, Murio E, Margarit C.

Transplant Proc. 1998 Jun;30(4):1432-4. No abstract available.

PMID:
9636580
40.

Vancomycin monitoring: one or two serum levels?

Andrés I, López R, Pou L, Piñol F, Pascual C.

Ther Drug Monit. 1997 Dec;19(6):614-9.

PMID:
9421100
41.

Comment: compatibility of amphotericin B with lipid emulsions.

Montoro JB, López RM, Pou L.

Ann Pharmacother. 1996 Dec;30(12):1501. No abstract available.

PMID:
8968472
42.
43.

Stability of amphotericin B in an extemporaneously prepared i.v. fat emulsion.

Lopez RM, Ayestaran A, Pou L, Montoro JB, Hernandez M, Caragol I.

Am J Health Syst Pharm. 1996 Nov 15;53(22):2724-7.

PMID:
8931814
44.

[Theophyllines of 12- and 24-hour sustained-release. Comparative study].

Vendrell M, Muñoz X, de Gracia J, Pou L, Morell F, Anguera A, Mayordomo C.

Arch Bronconeumol. 1996 Oct;32(8):397-402. Spanish.

PMID:
8983567
45.

Influence of biochemical parameters of liver function on vancomycin pharmacokinetics.

Martí R, Rosell M, Pou L, García L, Pascual C.

Pharmacol Toxicol. 1996 Aug;79(2):55-9.

PMID:
8878246
46.

Changes in vancomycin pharmacokinetics during treatment.

Pou L, Rosell M, Lopez R, Pascual C.

Ther Drug Monit. 1996 Apr;18(2):149-53.

PMID:
8721277
47.

Pharmacokinetics of conventional formulation versus fat emulsion formulation of amphotericin B in a group of patients with neutropenia.

Ayestarán A, López RM, Montoro JB, Estíbalez A, Pou L, Julià A, López A, Pascual B.

Antimicrob Agents Chemother. 1996 Mar;40(3):609-12.

48.

Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.

Gavaldà J, Cardona PJ, Almirante B, Capdevila JA, Laguarda M, Pou L, Crespo E, Pigrau C, Pahissa A.

Antimicrob Agents Chemother. 1996 Jan;40(1):173-8.

49.

Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin.

Gavaldà J, Pahissa A, Almirante B, Laguarda M, Crespo E, Pou L, Fernández F.

Antimicrob Agents Chemother. 1995 Sep;39(9):2098-103.

50.

[Zidovudine pharmacokinetics].

Sanz S, Altisent C, Montoro JB, Pou L.

Med Clin (Barc). 1993 Nov 27;101(18):717. Spanish. No abstract available.

PMID:
8114530

Supplemental Content

Support Center